AxoGen Inc. (NASDAQ:AXGN) Director Amy Mcbride Wendell purchased 13,333 shares of the company’s stock in a transaction dated Friday, October 7th. The shares were purchased at an average price of $7.50 per share, for a total transaction of $99,997.50. Following the completion of the purchase, the director now owns 13,333 shares of the company’s stock, valued at $99,997.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
AxoGen Inc. (NASDAQ:AXGN) opened at 8.75 on Wednesday. The firm’s market capitalization is $263.66 million. AxoGen Inc. has a 52 week low of $4.08 and a 52 week high of $9.88. The stock’s 50 day moving average is $8.73 and its 200-day moving average is $7.06.
AxoGen (NASDAQ:AXGN) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. On average, equities research analysts expect that AxoGen Inc. will post ($0.40) EPS for the current year.
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Fund Advisors increased its position in AxoGen by 1,049.1% in the second quarter. BlackRock Fund Advisors now owns 634,132 shares of the company’s stock worth $4,363,000 after buying an additional 578,948 shares during the last quarter. Vanguard Group Inc. increased its position in AxoGen by 61.5% in the second quarter. Vanguard Group Inc. now owns 775,448 shares of the company’s stock worth $5,335,000 after buying an additional 295,294 shares during the last quarter. State Street Corp acquired a new position in AxoGen during the second quarter worth about $1,885,000. Waddell & Reed Financial Inc. acquired a new position in AxoGen during the second quarter worth about $1,371,000. Finally, BlackRock Institutional Trust Company N.A. increased its position in AxoGen by 224.3% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 261,835 shares of the company’s stock worth $1,801,000 after buying an additional 181,086 shares during the last quarter. Institutional investors own 57.87% of the company’s stock.
Separately, Wedbush reiterated an “outperform” rating and set a $10.00 price target (up from $9.00) on shares of AxoGen in a research note on Thursday, August 4th.
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.